3,4-DGE is Important for Side Effects in Peritoneal Dialysis What About its Role in Diabetes

E-ISSN： 1875-533x|13|22|2695-2702

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.22, 2006-09, pp. : 2695-2702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Icodextrin: A Review of its Use in Peritoneal Dialysis

By Frampton J.E. Plosker G.L.

Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. : 2079-2105

Adis International

Access to resources Recommend Favorite

The Effects of Haemodialysis and Peritoneal Dialysis on Serum Lipoprotein(a) and C-reactive Protein Levels

By Borazan A Üstün H Yilmaz A

The Journal of International Medical Research, Vol. 31, Iss. 5, 2003-09 ,pp. : 378-383

Field House Publishing

Access to resources Recommend Favorite

Pharmacodynamics of Menatetrenone and Effects on Bone Metabolism in Continuous Ambulatory Peritoneal Dialysis Patients

By Sugimoto T Yamakado M Matsushita K Iwamoto T Tagawa H

The Journal of International Medical Research, Vol. 30, Iss. 6, 2002-11 ,pp. : 566-575

Field House Publishing

Access to resources Recommend Favorite

3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes

By Sanchez-Niño Maria Poveda Jonay Sanz Ana Carrasco Susana Ruiz-Ortega Marta Selgas Rafael Egido Jesus Ortiz Alberto

Archives of Toxicology, Vol. 88, Iss. 3, 2014-03 ,pp. : 597-608

Springer Publishing Company

Access to resources Recommend Favorite

Peritoneal Dialysis as an option for unplanned initiation of chronic dialysis

Hemodialysis International, Vol. 20, Iss. 4, 2016-10 ,pp. : 631-633

John Wiley & Sons Inc

Access to resources Recommend Favorite